On March 5, 2019, Scott Gottleib, the Commissioner of the Food and Drug Administrations (FDA) announced his resignation as of the end of March, 2019. This follows his recent statements as to the effect of the changes in law with respect to hemp under the 2018 Farm Bill (the “Farm Bill”). Under the Farm Bill
Healthcare
A Stark Reminder for Companies Involved in Cannabis Industry: Noncompliance with State Law Could Lead to Federal Prosecution
By Elizabeth Bogle & Leo D. Bronshteyn on
In a recent decision, United States v. Gilmore, the U.S. Court of Appeals for the Ninth Circuit reinforced the importance of complying with drug laws for doing business in the Cannabis industry. In Gilmore, hunters provided a tip to local authorities on a cannabis grow site in El Dorado County, California. Upon executing…
ALERT!! New Jersey Calls for New Applications for Cannabis Alternative Treatment Centers
By Elizabeth Bogle on
Since 5 new medical conditions were added to the list of conditions available for treatment with medical marijuana in the March 2018 Executive Order 6 Report, over 7,000 new patients have been added to the patient pool. Due to the significant expansion of the patient pool in the past few months, the New Jersey…
Room for Growth in New Jersey’s Medical Marijuana Program
By Elizabeth Bogle & Robert M. DiPisa on
On March 23, 2018, in response to Governor Murphy’s Executive Order 6 which directed the New Jersey Department of Health (“Department”) to review New Jersey’s Medical Marijuana Program (the “Medical Marijuana Program” or “Program”), the Department issued its report focusing on how to expand the Program’s scope and patient access to medical marijuana (the “…